title: Intravenous gammglobulin-associated acute renal failure.
abstract: Intravenous gammaglobulins are used for the treatment of various auto-immune hematological disorders. Renal failure is a relatively rare, but an increasingly recognized side effect of gammaglobulin therapy. Although the renal failure is usually reversible, renal replacement therapy is required occasionally. A high index of suspicion, early recognition and appropriate intervention can prevent this complication. We herewith describe two patients with an immune hematological disorder, who developed acute renal failure after treatment with intravenous gammaglobulins. A brief review of the possible risk factors, pathophysiology and management of this complication is provided.
authors: Long Island Jewish Medical Center, Department of Medicine, New Hyde Park, New York 11042, USA.
authors: N
authors: N
authors: Gupta
authors: I
authors: I
authors: Ahmed
authors: S
authors: S
authors: Nissel-Horowitz
authors: D
authors: D
authors: Patel
authors: B
authors: B
authors: Mehrotra
mesh_terms: D058186:Acute Kidney Injury / Q000139:chemically induced* / Q000209:etiology; D000368:Aged; D000369:Aged, 80 and over; D000744:Anemia, Hemolytic, Autoimmune / Q000150:complications / Q000188:drug therapy; D005260:Female; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000009:adverse effects*; D008297:Male; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000150:complications / Q000188:drug therapy; D012307:Risk Factors; D005719:gamma-Globulins / Q000008:administration & dosage / Q000009:adverse effects
chemical_list: D016756:Immunoglobulins, Intravenous; D005719:gamma-Globulins